Worldwide Healthcare Trust Stock Price To Sales
| WWH Stock | 359.50 0.50 0.14% |
Worldwide Healthcare Trust fundamentals help investors to digest information that contributes to Worldwide Healthcare's financial success or failures. It also enables traders to predict the movement of Worldwide Stock. The fundamental analysis module provides a way to measure Worldwide Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Worldwide Healthcare stock.
Worldwide | Price To Sales |
Worldwide Healthcare Trust Company Price To Sales Analysis
Worldwide Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Worldwide Healthcare Price To Sales | 10.10 X |
Most of Worldwide Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Worldwide Healthcare Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Worldwide Healthcare Trust has a Price To Sales of 10.0955 times. This is 367.38% higher than that of the Capital Markets sector and 57.25% higher than that of the Financials industry. The price to sales for all United Kingdom stocks is 11.6% higher than that of the company.
Worldwide Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Worldwide Healthcare's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Worldwide Healthcare could also be used in its relative valuation, which is a method of valuing Worldwide Healthcare by comparing valuation metrics of similar companies.Worldwide Healthcare is currently under evaluation in price to sales category among its peers.
Worldwide Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Worldwide Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Worldwide Healthcare's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Worldwide Fundamentals
| Return On Equity | 0.0951 | ||||
| Return On Asset | 0.0612 | ||||
| Profit Margin | 0.86 % | ||||
| Operating Margin | 0.96 % | ||||
| Current Valuation | 1.93 B | ||||
| Shares Outstanding | 530.42 M | ||||
| Shares Owned By Insiders | 0.39 % | ||||
| Shares Owned By Institutions | 74.46 % | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 10.10 X | ||||
| Revenue | 208.14 M | ||||
| Gross Profit | (129 M) | ||||
| EBITDA | 204.01 M | ||||
| Net Income | 212.14 M | ||||
| Total Debt | 68.94 M | ||||
| Book Value Per Share | 3.81 X | ||||
| Cash Flow From Operations | 2.26 M | ||||
| Earnings Per Share | 0.34 X | ||||
| Beta | 0.29 | ||||
| Market Capitalization | 1.87 B | ||||
| Total Asset | 2.19 B | ||||
| Retained Earnings | 20.82 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.19 B | ||||
| Last Dividend Paid | 0.028 |
About Worldwide Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Worldwide Healthcare Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Worldwide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Worldwide Healthcare Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Worldwide Stock
Worldwide Healthcare financial ratios help investors to determine whether Worldwide Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Worldwide with respect to the benefits of owning Worldwide Healthcare security.